| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:23 | DAX-Gewinner im September: Die fünf Top-Aktien im DAX - Diese 5 Aktien ließen die Konkurrenz hinter sich | 850 | wallstreetONLINE | © Foto: Rafael Henrique - picture allianceDer September bringt Bewegung in den DAX. Auf 30-Tage-Sicht konnten vor allem Qiagen, MTU Aero Engines und die Commerzbank überzeugen. Ein Überblick über die... ► Artikel lesen | |
| 16:38 | New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global | 333 | ACCESS Newswire | Gold-backed payments, enterprise AI, a Long COVID clinical readout and AI-powered school safety lead a 6:30 p.m. ET broadcast reaching audiences across the United States, Latin America and MENA NEW... ► Artikel lesen | |
| 12:30 | Heidelberg Pharma AG: Das Signal, das die meisten Anleger nicht auf dem Schirm haben | Hebelschein-Spekulant | |||
| 11:27 | Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months | 3 | The Motley Fool | ||
| 10:38 | Moderna: Dieses mRNA-Signal sollten Anleger kennen | 20 | Maximilian Berger | ||
| 07:27 | Aktien KW 39 Trump & Xi gegen die hohen Energiepreise? Dealmaker für Iran, Ukraine? Schön wäre es. Börsen glauben nicht so recht dran. News: Mutares. Verbio. Circus. ABO Energy. Heidelberg Pharma. KWS Saat. Nordex. ams Osram. Shelly. Berentzen | 2.437 | Nebenwerte Magazin | Aktien -unterm Strich bleibt ein kleines Plus in dieser Woche in Frankfurt. Im Fokus lagen diese Woche die steigenden Anleihezinsen, 10-jährige US-Bonds über 5%. Und weiter hohe Erdöl und Gaspreise... ► Artikel lesen | |
| 07:25 | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | Small- & Micro Cap Investment | |||
| 06:50 | RAIN-Token nach dem Enlivex-Stopp: Was du bei Zugang, Zwangsverkauf und Haltefrist prüfen musst | 13 | CryptoTicker | ||
| 02:46 | $10,000 invested in Pro Medicus and CSL shares 3 years ago is now worth… | 2 | The Motley Fool Australia | ||
| 00:18 | Kodiak Sciences to report phase 3 trial results Monday | 3 | Investing.com | ||
| Fr | Microbot Medical Inc.: Microbot Medical Highlights Growth Strategy | 222 | GlobeNewswire (Europe) | User Survey Demonstrates High Satisfaction of the LIBERTY System Expansion of Sales Footprint Expands to Western U.S. as Company Secures First California Customer HINGHAM, Mass., Sept. 25, 2026 (GLOBE... ► Artikel lesen | |
| Fr | Chemomab Therapeutics Ltd. - S-4, Registration of securities, business combinations | 1 | SEC Filings | ||
| Fr | DYADIC INTERNATIONAL INC - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Veracyte, Inc.: Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026 | 1 | GlobeNewswire (USA) | ||
| Fr | Calidi BioTherapeutics gets NYSE compliance warning but stock surprises | 2 | Seeking Alpha | ||
| Fr | Propanc Biopharma, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| Fr | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency | 330 | GlobeNewswire (Europe) | SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic... ► Artikel lesen | |
| Fr | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Crescent Biopharma, Inc.: Crescent Biopharma Announces Grants of Inducement Awards | 2 | GlobeNewswire (USA) | ||
| Fr | NervGen Pharma Corp.: NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments | 4 | GlobeNewswire (USA) |